Clinical Trial

Shortened High-dose Palliative Radiotherapy for Lung Cancer

Study acronym: SHiP-Rt
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The SHiP-Rt Study aims to investigate the safety and efficacy of reducing the number of RT fractions and RT duration, compared to the current standard of care (36Gy in 12 fractions over 16 days), by using shortened hypofractionated accelerated palliative radiotherapy (30Gy in 6 alternate-day fractions), aided by contemporary RT planning, verification, and delivery techniques.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-14
Trial Details
NCT Number NCT06483308
Lead Sponsor University Hospitals Coventry and Warwickshire NHS Trust
Conditions Stage IV Lung Cancer
Enrollment 37 participants
Start Date 2024-11-27
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13